Introduction
Studies in brain tissue preparations of the incorporation of radioactivity from different "C-labelled precursors (glucose, acetate and bicarbonate) into glutamate and glutamine have shown clearly that glutamate metabolism is extremely complicated [ 11.
Glutamine was found to attain a much higher specific radioactivity than its precursor glutamate and therefore two or more metabolically distinct pools of glutamate were envisaged, each being metabolized to glutamine with different turnover rates. Moreover, it was suggested that these pools could represent different cell types and it was predicted that glutamine synthesis from glutamate would be particularly prominent in one of these pools which in all likelihood would be localized in glial cells rather than in neurons. That this is indeed the case was firmly established with the elegant demonstration by Norenberg and Martinez-Hernandez [Z] that the glutamine-synthesizing enzyme glutamine synthetase is localized in astrocytes and not in neurons. As a consequence of this there must be a cycling of glutamate and glutamine between neurons and astrocytes and this cycling has been Abbreviations used: AAT, aspartate aminotransferase; GABA, y-aminobutyric acid; TCA, tricarboxylic acid. defined as the glutamate/glutamine cycle [3, 41.
During recent years it has become apparent that other amino acids and tricarboxylic acid cycle (TCA) constituents should also be considered as likely precursors for neurotransmitter glutamate [ 51.
The development of primary cultures of glutamatergic neurons and of astrocytes separately or in co-culture [6-91 has made it possible to study transmembrane fluxes as well as the biochemical conversions of glutamate and its precursors in the individual cell types. These studies have allowed a quantitative assessment of these parameters to be made [5, lo] . This review will provide an overview of the current status of knowledge about transmembrane fluxes of glutamate and some of its precursors as well as their apparent metabolic interconversions.
Transmem brane fluxes
Glutamate/glutamine On the basis of a large number of studies of glutamate uptake into primary cultures of glutarnatergic neurons and astrocytes from different brain areas (see [ 111) it can be concluded that the rate of astrocytic glutamate uptake is higher than the neuronal uptake rate. This is illustrated in Figure 1 which shows glutamate uptake into the two cell types at an
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Figure I
Schematic drawing of release and uptake of glutamate (*) and glutamine ( * ) from glutamatergic neurons and astrocytes
The release of glutamate corresponds t o that observed during excitation The sizes of the arrows give an estimate of the relative magnitudes of the respective fluxes It can be seen that the majority of the neuronally released glutamate is accumulated into astrocytes Moreover, it should be noted that very little glutamine is being released from glutamatergic neurons Figure 1 also shows the corresponding efflux of glutamate from such neurons and astrocytes and it can be seen that in the neurons there must be a net loss of glutamate during excitation and that this loss of glutamate is matched by a corresponding net uptake into astrocytes. Analogous studies of fluxes of glutamine have allowed similar calculations of rates of uptake and release of this amino acid to be performed, assuming that the extracellular glutamine concentration is 500 pM. Figure 1 shows that transmembrane fluxes of glutamine in the neurons and astrocytes are smaller than those of glutamate. It also shows that there is a net loss of glutamine from astrocytes and a net uptake of glutamine in glutamatergic neurons. However, in the neurons the uptake of glutamine does not correspond quantitatively to the loss of glutamate. It has therefore been postulated [11] [12] [13] [14] that other precursors for biosynthesis of transmitter glutamate, such as e.g. TCA cycle constituents, may exist. In order for a neuron to utilize TCA cycle constituents for biosynthesis of glutamate it must possess a biosynthetic pathway allowing a net synthesis of these constituents from glucose. This requires the presence of pyruvate carboxylase. However, pyruvate carboxylase is not present in neurons but only in astrocytes [15, 161. Thus, neurons are dependent on a supply of such precursors from astrocytes. This means that, regardless of whether the precursor for transmitter glutamate is glutamine or a TCA cycle constituent, a communication between neurons and astrocytes must take place as the astrocytes control the availability of these metabolites. This aspect will be dealt with in more detail below.
Alanine
It has been reported that during recirculation after an ischaemic insult in the rat hippocampus there is an overflow of alanine into the extracellular space [17] . A recent study [18] of metabolism of
[ 13C]glucose in neurons and astrocytes using n.m.r.
has provided evidence to suggest that alanine is likely to be preferentially synthesized in and released from astrocytes. A comparison [ 191 of the kinetic properties of alanine uptake in glutamatergic neurons and astrocytes has revealed that uptake is more efficient in the neurons (Vmax/Km -13 min-I) than in the astrocytes ( Vmax/K,,, -2 min-I). It is accordingly possible that alanine may be preferentially synthesized in astrocytes and subsequently released and taken up by glutamatergic neurons. The recent demonstration [20] that the amino group from alanine can be used to maintain the neurotransmitter pool of glutamate, provided aketoglutarate is supplied, agrees with such a function of alanine.
TCA cycle constituents
Several studies by '211 have provided evidence that TCA cycle constituents such as a-ketoglutarate and malate are preferentially taken up into nerve endings via high-affinity transport systems. Moreover, it has been observed that a close correlation exists between the rates of uptake of a-ketoglutarate and glutamate in different brain regions [21] . This may be taken to indicate that a-ketoglutarate could play a role as a precursor for transmitter glutamate. Indeed, in cultured glutamatergic neurons as well as in brain slices, aketoglutarate can maintain the release of transmitter glutamate [ZO, 221. It has recently been shown, however, that malate uptake into glutamatergic neurons is relatively slow albeit of high affinity "231. Moreover, it was not found to be superior to uptake into astrocytes [23] . In this context it should also be kept in mind that astrocytes but not neurons synthesize citrate from glucose and release it in considerable amounts [18, 191. 
Biosynthesis of glutamate
On the basis of a large number of studies in different brain tissue and cell preparations of labelling of releasable glutamate by different precursors, it can be concluded that glutamine plays a major role as a precursor for synthesis of transmitter glutamate [ 13, 241. However, as can be seen from Figure 2 , other compounds such as TCA cycle constituents [ 14,23, 241 may also serve this function. As pointed out above, due to the fact that neurons lack the capacity to synthesize all of these compounds, these metabolically handicapped cells are totally dependent on a supply from astrocytes which contain the enzymes glutamine synthetase and pyruvate carboxylase required for their synthesis [2, 15, 161. Using the aspartate aminotransferase (AAT) inhibitor, amino-oxyacetic acid, and the mitochondrial dicarboxylate carrier inhibitor, phenylsuccinate, it has been shown both in cultured cerebellar granule cells and in hippocampus in vivo that synthesis of transmitter glutamate from glutamine requires the activity of both AAT and the dicarboxylate carrier. It was proposed that glutamate formed from glutamine by glutaminase enters the mitochondria in exchange for aspartate. Subsequently, glutamate is transaminated in the matrix to form a-ketoglutarate and aspartate, and the a-ketoglutarate can be transported into the cytosol in exchange with malate, using the dicarboxylate carrier. Finally, glutamate is formed from 
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Concluding remarks
As highlighted above, the carbon skeleton of glutamate can be formed from glucose within the central nervous system, but a net synthesis from glucose can only occur in the presence of astrocytes, because it requires the participation of the anaplerotic enzyme pyruvate carboxylase which is not present in neurons. Glutamate is also the only amino acid that can be formed from the corresponding ketoacid by reductive amination, a process which, in contrast to transamination, leads to net amino acid synthesis from ammonia. The 'price' the glutamatergic cerebellar granule cells have 'paid to be 'allowed to release large amounts of this important and potentially lethal transmitter appears to be the following: (i) tight control of the formation of transmitter glutamate; (ii) inability to perform the net synthesis of TCA cycle constituents, required for a net synthesis of glutamate from glucose; and (iii) inability to use mitochondrial a-ketoglutarate together with ammonia for net synthesis of glutamate. Only glutamine and exogenous a-ketoglutarate or malate have been shown unequivocally to be suitable precursors for transmitter glutamate, and transamination processes are required for synthesis of transmitter glutamate regardless of which precursor is used. The suggested separation by the mitochondria1 membrane between intramitochondrial glutamate, derived directly from glutamine, and cytosolic glutamate, destined for transmitter release, must have an inhibitory influence on glutamate release.
With this strict and complicated control of production and release of transmitter glutamate it is unlikely that there would be an increased release of transmitter glutamate, e.g., during ischaemic conditions. In accordance with this concept is the accumulation of evidence that the increase in extracellular concentration of glutamate under ischaemia [ 171 is derived mainly from 'metabolic' pools. The ischaemia-induced increase of glutamate in synaptosomes or in the hippocampus during ischaemia in vivo is not calcium-dependent [29, 301, and phenylsuccinate, which prevents depolarization-coupled release of glutamate does not prevent the overflow of glutamate associated with ischaemia On this basis it appears that metabolic and neurotransmitter pools of glutamate play independent and important functional roles under normal and pathological conditions in the central nervous system. Detailed knowledge about key enzymes involved in the regulation of each of these pools therefore seems to be a prerequisite for design of pharmacological strategies to manipulate these pools individually.
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Glutamate release
The presynaptic mechanisms controlling the release of glutamate can be investigated at the level of the brain slice, neuronal cell culture or isolated nerve terminal. We have exploited this last preparation (also termed the synaptosome) using predominantly fluorometric techniques to determine the relationships between K + -channels, Ca' + -channels and glutamate release (Figure 1 ; for reviews see [8-lo] In addition to vesicular glutamate, the synaptosomes maintain a high concentration of glutamate in their cytoplasm. A gradient of > 1000-fold is maintained across the plasma membrane by the action of the acidic amino acid carrier, transporting a glutamate anion with (probably) 3Na+ in exchange for 1K+ [9] . This carrier is electrogenic and operates close to thermodynamic equilibrium, with the result that, when the plasma membrane is chronically depolarized, for example by elevated KCI, there is a redistribution of glutamate out of the cytoplasm [ 161. This carrier-mediated Ca2+ -independent release of glutamate is accompanied by aspartate, which is present in the cytoplasm but which does not appear to have access to the lumen of the synaptic vesicles [17] . During the normal millisecond time-course of physiological depolarization this carrier-mediated glutamate release would be negligible; however, it is an important component of most in vitro experiments and appears to be the major contributor to the massive excitotoxic release of glutamate which occurs in ischaemia.
The Caz+-channel coupled to amino acid release T o investigate glutamate exocytosis it is necessary to initiate the process by depolarizing the synaptosoma1 preparation. The classic method of elevated KCl activates Ca2+ channels causing a biphasic entry of 45Ca [ 181 which generates a slight 'spike' in cytoplasmic free Ca2 + concentration (monitored by preloaded fura-2) followed by a prolonged plateau. The release of glutamate may be followed by a parallel fluorometric assay [ 191 monitoring 
